Abstract
Primate T-lymphotropic virus species comprise four members (HTLV-1 to -4) that have been discovered in human. Only the HTLV-1 infection leads to adult T-cell leukemia/lymphoma (ATLL). All the four viruses share a similar genomic organization and encode transforming Tax oncoproteins. In contrast to HTLV-2 and 4, HTLV-1 and 3 Tax proteins contain a PSD-95/Drosophila Discs Large/Zona Occludens-I (PDZ) binding motif at their C-terminal that has been shown to play crucial roles in the distinct transforming properties of the Tax proteins. Here, we used a collection of human full-length protein-coding open reading frames (ORFeome v3.1) to identify novel PDZ domain containing proteins that specifically interact with HTLV-1 Tax. Novel Tax interactors include syntenin-1 and -2, LNX2, DVL3, GIPC2, INTU, PDLIM4 and -7, RADIL and RGS3. These proteins are involved in diverse biological processes including cell division, cell fate determination, and cell survival. We further characterized interaction between Tax and syntenins and showed that, FJ9 a small molecule able to disrupt Tax/PDZ interactions, could antagonize Tax-transformation activity in a Rat-1 model. Our study identify novel PDZ-containing proteins interacting with HTLV-1 Tax and provides the first example where Tax protein-protein interactions with PDZ containing proteins and Tax-transformation capacity could be inhibited by a small molecule.
Highlights
Primate T-lymphotropic virus species comprise four members (HTLV-1 to -4) that have been discovered in human
The HTLV-1 infection leads to adult T-cell leukemia/lymphoma (ATLL)
We used a collection of human full-length protein-coding open reading frames (ORFeome v3.1) to identify novel PSD-95/Drosophila Discs Large/Zona Occludens-I (PDZ) domain containing proteins that interact with HTLV-1 Tax
Summary
Primate T-lymphotropic virus species comprise four members (HTLV-1 to -4) that have been discovered in human. Inhibition of Tax transformation activity using a small molecule targeting Tax/PDZ domain interactions Karim Blibek1*, Naoaki Fujii2, Sebastien Legros1, Mathieu Boxus1, Jean-François Dewulf1, Pascale Zimmermann3, Richard Kettmann1, Franck Dequiedt1, Jean-Claude Twizere1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.